nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA8—artery—uterine cancer	0.02	0.0716	CbGeAlD
Zonisamide—CA6—exocrine gland—uterine cancer	0.00806	0.0289	CbGeAlD
Zonisamide—SCN4B—myometrium—uterine cancer	0.00806	0.0289	CbGeAlD
Zonisamide—CA11—myometrium—uterine cancer	0.00693	0.0249	CbGeAlD
Zonisamide—CA8—endometrium—uterine cancer	0.00679	0.0244	CbGeAlD
Zonisamide—SCN4B—uterine cervix—uterine cancer	0.00627	0.0225	CbGeAlD
Zonisamide—SCN1B—female reproductive system—uterine cancer	0.00599	0.0215	CbGeAlD
Zonisamide—CA10—female reproductive system—uterine cancer	0.00574	0.0206	CbGeAlD
Zonisamide—SCN4B—mammalian vulva—uterine cancer	0.00549	0.0197	CbGeAlD
Zonisamide—CA11—uterine cervix—uterine cancer	0.0054	0.0193	CbGeAlD
Zonisamide—CA11—decidua—uterine cancer	0.00514	0.0184	CbGeAlD
Zonisamide—SCN3B—vagina—uterine cancer	0.005	0.0179	CbGeAlD
Zonisamide—CA11—endometrium—uterine cancer	0.00488	0.0175	CbGeAlD
Zonisamide—CA11—mammalian vulva—uterine cancer	0.00472	0.0169	CbGeAlD
Zonisamide—CA11—uterus—uterine cancer	0.0045	0.0161	CbGeAlD
Zonisamide—CA13—female gonad—uterine cancer	0.00438	0.0157	CbGeAlD
Zonisamide—CA13—vagina—uterine cancer	0.00436	0.0156	CbGeAlD
Zonisamide—SCN4B—vagina—uterine cancer	0.00425	0.0152	CbGeAlD
Zonisamide—CA3—myometrium—uterine cancer	0.00423	0.0152	CbGeAlD
Zonisamide—CA5A—female reproductive system—uterine cancer	0.00404	0.0145	CbGeAlD
Zonisamide—CA11—female reproductive system—uterine cancer	0.00404	0.0145	CbGeAlD
Zonisamide—CACNA1G—decidua—uterine cancer	0.004	0.0143	CbGeAlD
Zonisamide—CA11—female gonad—uterine cancer	0.00368	0.0132	CbGeAlD
Zonisamide—CA11—vagina—uterine cancer	0.00366	0.0131	CbGeAlD
Zonisamide—CACNA1H—myometrium—uterine cancer	0.00353	0.0126	CbGeAlD
Zonisamide—SCN1B—lymph node—uterine cancer	0.0035	0.0126	CbGeAlD
Zonisamide—CA7—renal system—uterine cancer	0.00336	0.012	CbGeAlD
Zonisamide—CA3—uterine cervix—uterine cancer	0.00329	0.0118	CbGeAlD
Zonisamide—CA8—lymph node—uterine cancer	0.00329	0.0118	CbGeAlD
Zonisamide—SCN3B—lymph node—uterine cancer	0.00323	0.0116	CbGeAlD
Zonisamide—CA13—lymph node—uterine cancer	0.00282	0.0101	CbGeAlD
Zonisamide—CA2—exocrine gland—uterine cancer	0.00278	0.00995	CbGeAlD
Zonisamide—SCN4B—lymph node—uterine cancer	0.00275	0.00985	CbGeAlD
Zonisamide—CA3—uterus—uterine cancer	0.00274	0.00984	CbGeAlD
Zonisamide—CACNA1I—lymph node—uterine cancer	0.00268	0.00962	CbGeAlD
Zonisamide—CACNA1H—smooth muscle tissue—uterine cancer	0.00267	0.00956	CbGeAlD
Zonisamide—AOX1—myometrium—uterine cancer	0.0025	0.00896	CbGeAlD
Zonisamide—SCN4A—renal system—uterine cancer	0.00245	0.00876	CbGeAlD
Zonisamide—CA11—lymph node—uterine cancer	0.00237	0.00848	CbGeAlD
Zonisamide—CA9—female reproductive system—uterine cancer	0.00236	0.00847	CbGeAlD
Zonisamide—CACNA1H—uterus—uterine cancer	0.00229	0.0082	CbGeAlD
Zonisamide—CA3—vagina—uterine cancer	0.00223	0.008	CbGeAlD
Zonisamide—CA12—renal system—uterine cancer	0.00218	0.00782	CbGeAlD
Zonisamide—CACNA1H—female reproductive system—uterine cancer	0.00206	0.00737	CbGeAlD
Zonisamide—AOX1—uterine cervix—uterine cancer	0.00195	0.00697	CbGeAlD
Zonisamide—SCN3A—decidua—uterine cancer	0.00194	0.00694	CbGeAlD
Zonisamide—MAOB—myometrium—uterine cancer	0.00193	0.00691	CbGeAlD
Zonisamide—SCN3A—renal system—uterine cancer	0.0019	0.00682	CbGeAlD
Zonisamide—CACNA1H—female gonad—uterine cancer	0.00187	0.00671	CbGeAlD
Zonisamide—AOX1—decidua—uterine cancer	0.00185	0.00664	CbGeAlD
Zonisamide—CA5B—mammalian vulva—uterine cancer	0.00183	0.00656	CbGeAlD
Zonisamide—AOX1—renal system—uterine cancer	0.00182	0.00652	CbGeAlD
Zonisamide—AOX1—endometrium—uterine cancer	0.00176	0.00631	CbGeAlD
Zonisamide—CA12—female reproductive system—uterine cancer	0.00175	0.00626	CbGeAlD
Zonisamide—CA1—renal system—uterine cancer	0.00173	0.00619	CbGeAlD
Zonisamide—AOX1—mammalian vulva—uterine cancer	0.0017	0.0061	CbGeAlD
Zonisamide—MAOA—myometrium—uterine cancer	0.00164	0.00589	CbGeAlD
Zonisamide—AOX1—uterus—uterine cancer	0.00162	0.00581	CbGeAlD
Zonisamide—SCN2A—vagina—uterine cancer	0.00157	0.00562	CbGeAlD
Zonisamide—CA5B—female reproductive system—uterine cancer	0.00157	0.00562	CbGeAlD
Zonisamide—SCN3A—female reproductive system—uterine cancer	0.00152	0.00546	CbGeAlD
Zonisamide—MAOB—uterine cervix—uterine cancer	0.0015	0.00537	CbGeAlD
Zonisamide—AOX1—female reproductive system—uterine cancer	0.00146	0.00523	CbGeAlD
Zonisamide—CA3—lymph node—uterine cancer	0.00144	0.00517	CbGeAlD
Zonisamide—MAOB—decidua—uterine cancer	0.00143	0.00512	CbGeAlD
Zonisamide—CA5B—vagina—uterine cancer	0.00142	0.00508	CbGeAlD
Zonisamide—MAOB—renal system—uterine cancer	0.0014	0.00503	CbGeAlD
Zonisamide—CA1—female reproductive system—uterine cancer	0.00138	0.00496	CbGeAlD
Zonisamide—SCN3A—vagina—uterine cancer	0.00138	0.00494	CbGeAlD
Zonisamide—SCN5A—vagina—uterine cancer	0.00137	0.00492	CbGeAlD
Zonisamide—MAOB—endometrium—uterine cancer	0.00136	0.00486	CbGeAlD
Zonisamide—CA4—renal system—uterine cancer	0.00135	0.00484	CbGeAlD
Zonisamide—AOX1—female gonad—uterine cancer	0.00133	0.00475	CbGeAlD
Zonisamide—AOX1—vagina—uterine cancer	0.00132	0.00473	CbGeAlD
Zonisamide—MAOB—mammalian vulva—uterine cancer	0.00131	0.0047	CbGeAlD
Zonisamide—SCN9A—lymph node—uterine cancer	0.00128	0.0046	CbGeAlD
Zonisamide—MAOA—uterine cervix—uterine cancer	0.00128	0.00458	CbGeAlD
Zonisamide—MAOB—uterus—uterine cancer	0.00125	0.00448	CbGeAlD
Zonisamide—MAOA—decidua—uterine cancer	0.00122	0.00437	CbGeAlD
Zonisamide—CA2—epithelium—uterine cancer	0.00121	0.00433	CbGeAlD
Zonisamide—CACNA1H—lymph node—uterine cancer	0.0012	0.00431	CbGeAlD
Zonisamide—MAOA—renal system—uterine cancer	0.0012	0.00429	CbGeAlD
Zonisamide—CA2—smooth muscle tissue—uterine cancer	0.00116	0.00417	CbGeAlD
Zonisamide—MAOA—endometrium—uterine cancer	0.00116	0.00415	CbGeAlD
Zonisamide—CA2—decidua—uterine cancer	0.00114	0.00409	CbGeAlD
Zonisamide—MAOB—female reproductive system—uterine cancer	0.00112	0.00403	CbGeAlD
Zonisamide—CA2—renal system—uterine cancer	0.00112	0.00402	CbGeAlD
Zonisamide—MAOA—mammalian vulva—uterine cancer	0.00112	0.00401	CbGeAlD
Zonisamide—CA4—female reproductive system—uterine cancer	0.00108	0.00388	CbGeAlD
Zonisamide—MAOA—uterus—uterine cancer	0.00107	0.00382	CbGeAlD
Zonisamide—CA2—mammalian vulva—uterine cancer	0.00105	0.00375	CbGeAlD
Zonisamide—MAOB—female gonad—uterine cancer	0.00102	0.00366	CbGeAlD
Zonisamide—MAOB—vagina—uterine cancer	0.00102	0.00364	CbGeAlD
Zonisamide—CA4—female gonad—uterine cancer	0.000985	0.00353	CbGeAlD
Zonisamide—MAOA—female reproductive system—uterine cancer	0.000958	0.00344	CbGeAlD
Zonisamide—CA5B—lymph node—uterine cancer	0.000917	0.00329	CbGeAlD
Zonisamide—CA2—female reproductive system—uterine cancer	0.000897	0.00322	CbGeAlD
Zonisamide—SCN3A—lymph node—uterine cancer	0.000891	0.00319	CbGeAlD
Zonisamide—CYP2C19—vagina—uterine cancer	0.000885	0.00317	CbGeAlD
Zonisamide—MAOA—female gonad—uterine cancer	0.000872	0.00313	CbGeAlD
Zonisamide—MAOA—vagina—uterine cancer	0.000867	0.00311	CbGeAlD
Zonisamide—AOX1—lymph node—uterine cancer	0.000853	0.00306	CbGeAlD
Zonisamide—CA2—female gonad—uterine cancer	0.000816	0.00293	CbGeAlD
Zonisamide—CA2—vagina—uterine cancer	0.000811	0.00291	CbGeAlD
Zonisamide—CA1—lymph node—uterine cancer	0.00081	0.0029	CbGeAlD
Zonisamide—CYP3A4—renal system—uterine cancer	0.000723	0.00259	CbGeAlD
Zonisamide—MAOB—lymph node—uterine cancer	0.000657	0.00236	CbGeAlD
Zonisamide—CA4—lymph node—uterine cancer	0.000633	0.00227	CbGeAlD
Zonisamide—CYP3A4—female reproductive system—uterine cancer	0.000579	0.00207	CbGeAlD
Zonisamide—MAOA—lymph node—uterine cancer	0.000561	0.00201	CbGeAlD
Zonisamide—CA2—lymph node—uterine cancer	0.000525	0.00188	CbGeAlD
Zonisamide—Dry skin—Epirubicin—uterine cancer	0.000384	0.000731	CcSEcCtD
Zonisamide—Chest pain—Etoposide—uterine cancer	0.000383	0.000729	CcSEcCtD
Zonisamide—Affect lability—Doxorubicin—uterine cancer	0.000382	0.000726	CcSEcCtD
Zonisamide—Hypokalaemia—Epirubicin—uterine cancer	0.000382	0.000725	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000381	0.000724	CcSEcCtD
Zonisamide—Discomfort—Etoposide—uterine cancer	0.000379	0.00072	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000378	0.000718	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000378	0.000718	CcSEcCtD
Zonisamide—Face oedema—Doxorubicin—uterine cancer	0.000374	0.000712	CcSEcCtD
Zonisamide—Hypersensitivity—Dactinomycin—uterine cancer	0.000374	0.000712	CcSEcCtD
Zonisamide—Gastritis—Epirubicin—uterine cancer	0.000371	0.000706	CcSEcCtD
Zonisamide—Confusional state—Etoposide—uterine cancer	0.000371	0.000705	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00037	0.000703	CcSEcCtD
Zonisamide—Muscular weakness—Epirubicin—uterine cancer	0.00037	0.000703	CcSEcCtD
Zonisamide—Mood swings—Doxorubicin—uterine cancer	0.000367	0.000699	CcSEcCtD
Zonisamide—Infection—Etoposide—uterine cancer	0.000365	0.000694	CcSEcCtD
Zonisamide—Ataxia—Doxorubicin—uterine cancer	0.000365	0.000694	CcSEcCtD
Zonisamide—Asthenia—Dactinomycin—uterine cancer	0.000364	0.000693	CcSEcCtD
Zonisamide—Blood creatinine increased—Doxorubicin—uterine cancer	0.000363	0.000691	CcSEcCtD
Zonisamide—Dysphagia—Epirubicin—uterine cancer	0.000362	0.000689	CcSEcCtD
Zonisamide—Influenza—Epirubicin—uterine cancer	0.000362	0.000689	CcSEcCtD
Zonisamide—Dehydration—Doxorubicin—uterine cancer	0.000361	0.000686	CcSEcCtD
Zonisamide—Thrombocytopenia—Etoposide—uterine cancer	0.00036	0.000684	CcSEcCtD
Zonisamide—Tachycardia—Etoposide—uterine cancer	0.000359	0.000682	CcSEcCtD
Zonisamide—Eosinophilia—Epirubicin—uterine cancer	0.000359	0.000682	CcSEcCtD
Zonisamide—Liver function test abnormal—Doxorubicin—uterine cancer	0.000358	0.000681	CcSEcCtD
Zonisamide—Skin disorder—Etoposide—uterine cancer	0.000357	0.000679	CcSEcCtD
Zonisamide—Dry skin—Doxorubicin—uterine cancer	0.000356	0.000676	CcSEcCtD
Zonisamide—Hyperhidrosis—Etoposide—uterine cancer	0.000355	0.000676	CcSEcCtD
Zonisamide—Pancreatitis—Epirubicin—uterine cancer	0.000355	0.000676	CcSEcCtD
Zonisamide—Hypokalaemia—Doxorubicin—uterine cancer	0.000353	0.000671	CcSEcCtD
Zonisamide—Anorexia—Etoposide—uterine cancer	0.00035	0.000666	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000349	0.000664	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000349	0.000664	CcSEcCtD
Zonisamide—Diarrhoea—Dactinomycin—uterine cancer	0.000348	0.000661	CcSEcCtD
Zonisamide—Pancytopenia—Epirubicin—uterine cancer	0.000344	0.000654	CcSEcCtD
Zonisamide—Hypotension—Etoposide—uterine cancer	0.000343	0.000653	CcSEcCtD
Zonisamide—Gastritis—Doxorubicin—uterine cancer	0.000343	0.000653	CcSEcCtD
Zonisamide—Muscular weakness—Doxorubicin—uterine cancer	0.000342	0.000651	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000342	0.000651	CcSEcCtD
Zonisamide—Dysuria—Epirubicin—uterine cancer	0.000339	0.000644	CcSEcCtD
Zonisamide—Dysphagia—Doxorubicin—uterine cancer	0.000335	0.000638	CcSEcCtD
Zonisamide—Influenza—Doxorubicin—uterine cancer	0.000335	0.000638	CcSEcCtD
Zonisamide—Pollakiuria—Epirubicin—uterine cancer	0.000335	0.000636	CcSEcCtD
Zonisamide—Eosinophilia—Doxorubicin—uterine cancer	0.000332	0.000631	CcSEcCtD
Zonisamide—Paraesthesia—Etoposide—uterine cancer	0.00033	0.000628	CcSEcCtD
Zonisamide—Weight increased—Epirubicin—uterine cancer	0.00033	0.000627	CcSEcCtD
Zonisamide—Pancreatitis—Doxorubicin—uterine cancer	0.000329	0.000625	CcSEcCtD
Zonisamide—Weight decreased—Epirubicin—uterine cancer	0.000328	0.000623	CcSEcCtD
Zonisamide—Dyspnoea—Etoposide—uterine cancer	0.000328	0.000623	CcSEcCtD
Zonisamide—Somnolence—Etoposide—uterine cancer	0.000327	0.000621	CcSEcCtD
Zonisamide—Pneumonia—Epirubicin—uterine cancer	0.000325	0.000618	CcSEcCtD
Zonisamide—Vomiting—Dactinomycin—uterine cancer	0.000323	0.000614	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00032	0.000609	CcSEcCtD
Zonisamide—Rash—Dactinomycin—uterine cancer	0.00032	0.000609	CcSEcCtD
Zonisamide—Decreased appetite—Etoposide—uterine cancer	0.00032	0.000608	CcSEcCtD
Zonisamide—Pancytopenia—Doxorubicin—uterine cancer	0.000318	0.000605	CcSEcCtD
Zonisamide—Renal failure—Epirubicin—uterine cancer	0.000318	0.000604	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000317	0.000603	CcSEcCtD
Zonisamide—Fatigue—Etoposide—uterine cancer	0.000317	0.000603	CcSEcCtD
Zonisamide—Neuropathy peripheral—Epirubicin—uterine cancer	0.000317	0.000602	CcSEcCtD
Zonisamide—Stomatitis—Epirubicin—uterine cancer	0.000315	0.000599	CcSEcCtD
Zonisamide—Constipation—Etoposide—uterine cancer	0.000314	0.000598	CcSEcCtD
Zonisamide—Conjunctivitis—Epirubicin—uterine cancer	0.000314	0.000597	CcSEcCtD
Zonisamide—Urinary tract infection—Epirubicin—uterine cancer	0.000314	0.000597	CcSEcCtD
Zonisamide—Dysuria—Doxorubicin—uterine cancer	0.000314	0.000596	CcSEcCtD
Zonisamide—Sweating—Epirubicin—uterine cancer	0.00031	0.000589	CcSEcCtD
Zonisamide—Pollakiuria—Doxorubicin—uterine cancer	0.00031	0.000589	CcSEcCtD
Zonisamide—Haematuria—Epirubicin—uterine cancer	0.000308	0.000586	CcSEcCtD
Zonisamide—Hepatobiliary disease—Epirubicin—uterine cancer	0.000306	0.000581	CcSEcCtD
Zonisamide—Weight increased—Doxorubicin—uterine cancer	0.000305	0.00058	CcSEcCtD
Zonisamide—Weight decreased—Doxorubicin—uterine cancer	0.000303	0.000577	CcSEcCtD
Zonisamide—Feeling abnormal—Etoposide—uterine cancer	0.000303	0.000576	CcSEcCtD
Zonisamide—Nausea—Dactinomycin—uterine cancer	0.000302	0.000574	CcSEcCtD
Zonisamide—Agranulocytosis—Epirubicin—uterine cancer	0.000301	0.000573	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—uterine cancer	0.000301	0.000572	CcSEcCtD
Zonisamide—Gastrointestinal pain—Etoposide—uterine cancer	0.000301	0.000572	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000296	0.000564	CcSEcCtD
Zonisamide—Bradycardia—Epirubicin—uterine cancer	0.000295	0.000561	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—uterine cancer	0.000294	0.000559	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000293	0.000557	CcSEcCtD
Zonisamide—Urticaria—Etoposide—uterine cancer	0.000292	0.000555	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—uterine cancer	0.000291	0.000554	CcSEcCtD
Zonisamide—Rhinitis—Epirubicin—uterine cancer	0.000291	0.000553	CcSEcCtD
Zonisamide—Abdominal pain—Etoposide—uterine cancer	0.000291	0.000553	CcSEcCtD
Zonisamide—Body temperature increased—Etoposide—uterine cancer	0.000291	0.000553	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—uterine cancer	0.000291	0.000553	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—uterine cancer	0.000291	0.000553	CcSEcCtD
Zonisamide—Pharyngitis—Epirubicin—uterine cancer	0.000288	0.000547	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—uterine cancer	0.000287	0.000545	CcSEcCtD
Zonisamide—Urinary tract disorder—Epirubicin—uterine cancer	0.000286	0.000545	CcSEcCtD
Zonisamide—Oedema peripheral—Epirubicin—uterine cancer	0.000286	0.000543	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—uterine cancer	0.000285	0.000542	CcSEcCtD
Zonisamide—Connective tissue disorder—Epirubicin—uterine cancer	0.000285	0.000542	CcSEcCtD
Zonisamide—Urethral disorder—Epirubicin—uterine cancer	0.000284	0.000541	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000283	0.000538	CcSEcCtD
Zonisamide—Agranulocytosis—Doxorubicin—uterine cancer	0.000279	0.00053	CcSEcCtD
Zonisamide—Erythema multiforme—Epirubicin—uterine cancer	0.000274	0.000521	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—uterine cancer	0.000273	0.000519	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—uterine cancer	0.000271	0.000515	CcSEcCtD
Zonisamide—Hypersensitivity—Etoposide—uterine cancer	0.000271	0.000515	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—uterine cancer	0.00027	0.000514	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—uterine cancer	0.000269	0.000512	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—uterine cancer	0.000266	0.000506	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000265	0.000504	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—uterine cancer	0.000264	0.000503	CcSEcCtD
Zonisamide—Asthenia—Etoposide—uterine cancer	0.000264	0.000501	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—uterine cancer	0.000264	0.000501	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—uterine cancer	0.000263	0.0005	CcSEcCtD
Zonisamide—Immune system disorder—Epirubicin—uterine cancer	0.000262	0.000498	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—uterine cancer	0.000261	0.000497	CcSEcCtD
Zonisamide—Pruritus—Etoposide—uterine cancer	0.00026	0.000495	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—uterine cancer	0.000256	0.000487	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—uterine cancer	0.000254	0.000483	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—uterine cancer	0.000254	0.000482	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—uterine cancer	0.000252	0.00048	CcSEcCtD
Zonisamide—Diarrhoea—Etoposide—uterine cancer	0.000252	0.000478	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—uterine cancer	0.000251	0.000477	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—uterine cancer	0.00025	0.000476	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—uterine cancer	0.000249	0.000473	CcSEcCtD
Zonisamide—Tension—Epirubicin—uterine cancer	0.000248	0.000471	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—uterine cancer	0.000247	0.00047	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—uterine cancer	0.000245	0.000466	CcSEcCtD
Zonisamide—Dizziness—Etoposide—uterine cancer	0.000243	0.000462	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—uterine cancer	0.000243	0.000462	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—uterine cancer	0.000242	0.000461	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—uterine cancer	0.000242	0.00046	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—uterine cancer	0.000237	0.000451	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—uterine cancer	0.000235	0.000447	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—uterine cancer	0.000234	0.000445	CcSEcCtD
Zonisamide—Vomiting—Etoposide—uterine cancer	0.000234	0.000444	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—uterine cancer	0.000234	0.000444	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—uterine cancer	0.000233	0.000444	CcSEcCtD
Zonisamide—Agitation—Epirubicin—uterine cancer	0.000232	0.000441	CcSEcCtD
Zonisamide—Rash—Etoposide—uterine cancer	0.000232	0.000441	CcSEcCtD
Zonisamide—Dermatitis—Etoposide—uterine cancer	0.000232	0.00044	CcSEcCtD
Zonisamide—Headache—Etoposide—uterine cancer	0.00023	0.000438	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—uterine cancer	0.00023	0.000438	CcSEcCtD
Zonisamide—Tension—Doxorubicin—uterine cancer	0.000229	0.000436	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—uterine cancer	0.000229	0.000435	CcSEcCtD
Zonisamide—Malaise—Epirubicin—uterine cancer	0.000228	0.000433	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—uterine cancer	0.000227	0.000431	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—uterine cancer	0.000227	0.000431	CcSEcCtD
Zonisamide—Syncope—Epirubicin—uterine cancer	0.000226	0.000431	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—uterine cancer	0.000226	0.00043	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—uterine cancer	0.000225	0.000427	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—uterine cancer	0.000223	0.000424	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—uterine cancer	0.000222	0.000422	CcSEcCtD
Zonisamide—Cough—Epirubicin—uterine cancer	0.00022	0.000419	CcSEcCtD
Zonisamide—Convulsion—Epirubicin—uterine cancer	0.000219	0.000416	CcSEcCtD
Zonisamide—Nausea—Etoposide—uterine cancer	0.000218	0.000415	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—uterine cancer	0.000218	0.000414	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000217	0.000412	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—uterine cancer	0.000216	0.000411	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—uterine cancer	0.000215	0.000409	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—uterine cancer	0.000215	0.000409	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—uterine cancer	0.000215	0.000409	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—uterine cancer	0.000215	0.000408	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—uterine cancer	0.000214	0.000407	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000213	0.000406	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—uterine cancer	0.000212	0.000404	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—uterine cancer	0.000211	0.000401	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—uterine cancer	0.00021	0.0004	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—uterine cancer	0.00021	0.000399	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—uterine cancer	0.000209	0.000398	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—uterine cancer	0.000209	0.000398	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—uterine cancer	0.000208	0.000395	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—uterine cancer	0.000206	0.000393	CcSEcCtD
Zonisamide—Oedema—Epirubicin—uterine cancer	0.000206	0.000392	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—uterine cancer	0.000205	0.00039	CcSEcCtD
Zonisamide—Infection—Epirubicin—uterine cancer	0.000205	0.000389	CcSEcCtD
Zonisamide—Cough—Doxorubicin—uterine cancer	0.000204	0.000388	CcSEcCtD
Zonisamide—Shock—Epirubicin—uterine cancer	0.000203	0.000385	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—uterine cancer	0.000202	0.000385	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—uterine cancer	0.000202	0.000384	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000202	0.000384	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—uterine cancer	0.000202	0.000384	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—uterine cancer	0.000201	0.000382	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—uterine cancer	0.0002	0.000381	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—uterine cancer	0.000199	0.000379	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—uterine cancer	0.000199	0.000378	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—uterine cancer	0.000199	0.000378	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—uterine cancer	0.000199	0.000378	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—uterine cancer	0.000198	0.000377	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000198	0.000376	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—uterine cancer	0.000196	0.000374	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—uterine cancer	0.000196	0.000373	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—uterine cancer	0.000195	0.00037	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—uterine cancer	0.000193	0.000366	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—uterine cancer	0.000192	0.000366	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—uterine cancer	0.000191	0.000363	CcSEcCtD
Zonisamide—Infection—Doxorubicin—uterine cancer	0.000189	0.00036	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000188	0.000357	CcSEcCtD
Zonisamide—Shock—Doxorubicin—uterine cancer	0.000188	0.000357	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—uterine cancer	0.000187	0.000356	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000187	0.000355	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—uterine cancer	0.000186	0.000354	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—uterine cancer	0.000186	0.000354	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—uterine cancer	0.000185	0.000352	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—uterine cancer	0.000185	0.000352	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000184	0.00035	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—uterine cancer	0.000184	0.000349	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—uterine cancer	0.000183	0.000348	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—uterine cancer	0.000182	0.000346	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—uterine cancer	0.000181	0.000345	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—uterine cancer	0.000179	0.000341	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—uterine cancer	0.000178	0.000339	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000178	0.000338	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—uterine cancer	0.000178	0.000338	CcSEcCtD
Zonisamide—Constipation—Epirubicin—uterine cancer	0.000176	0.000335	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000174	0.00033	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—uterine cancer	0.000172	0.000328	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—uterine cancer	0.000171	0.000326	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—uterine cancer	0.00017	0.000323	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—uterine cancer	0.00017	0.000323	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—uterine cancer	0.000169	0.000322	CcSEcCtD
Zonisamide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000168	0.00032	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—uterine cancer	0.000168	0.000319	CcSEcCtD
Zonisamide—Decreased appetite—Doxorubicin—uterine cancer	0.000166	0.000315	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000165	0.000313	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—uterine cancer	0.000164	0.000313	CcSEcCtD
Zonisamide—Urticaria—Epirubicin—uterine cancer	0.000164	0.000311	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—uterine cancer	0.000163	0.00031	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—uterine cancer	0.000163	0.00031	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—uterine cancer	0.000163	0.00031	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—uterine cancer	0.000157	0.000299	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000156	0.000296	CcSEcCtD
Zonisamide—Hypersensitivity—Epirubicin—uterine cancer	0.000152	0.000289	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—uterine cancer	0.000151	0.000288	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—uterine cancer	0.000151	0.000287	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—uterine cancer	0.000151	0.000287	CcSEcCtD
Zonisamide—Asthenia—Epirubicin—uterine cancer	0.000148	0.000281	CcSEcCtD
Zonisamide—Pruritus—Epirubicin—uterine cancer	0.000146	0.000277	CcSEcCtD
Zonisamide—Diarrhoea—Epirubicin—uterine cancer	0.000141	0.000268	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—uterine cancer	0.00014	0.000267	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—uterine cancer	0.000137	0.00026	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—uterine cancer	0.000136	0.000259	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—uterine cancer	0.000135	0.000256	CcSEcCtD
Zonisamide—Vomiting—Epirubicin—uterine cancer	0.000131	0.000249	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—uterine cancer	0.00013	0.000248	CcSEcCtD
Zonisamide—Rash—Epirubicin—uterine cancer	0.00013	0.000247	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—uterine cancer	0.00013	0.000247	CcSEcCtD
Zonisamide—Headache—Epirubicin—uterine cancer	0.000129	0.000245	CcSEcCtD
Zonisamide—Dizziness—Doxorubicin—uterine cancer	0.000126	0.00024	CcSEcCtD
Zonisamide—Nausea—Epirubicin—uterine cancer	0.000122	0.000233	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—uterine cancer	0.000121	0.000231	CcSEcCtD
Zonisamide—Rash—Doxorubicin—uterine cancer	0.00012	0.000229	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—uterine cancer	0.00012	0.000228	CcSEcCtD
Zonisamide—Headache—Doxorubicin—uterine cancer	0.000119	0.000227	CcSEcCtD
Zonisamide—Nausea—Doxorubicin—uterine cancer	0.000113	0.000215	CcSEcCtD
Zonisamide—SCN9A—Axon guidance—KRAS—uterine cancer	9.77e-05	0.000501	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—EP300—uterine cancer	9.7e-05	0.000497	CbGpPWpGaD
Zonisamide—CA9—Metabolism—RRM2—uterine cancer	9.67e-05	0.000496	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKR1C3—uterine cancer	9.5e-05	0.000487	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—CTNNB1—uterine cancer	9.48e-05	0.000486	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—ERBB2—uterine cancer	9.43e-05	0.000483	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—KRAS—uterine cancer	9.42e-05	0.000483	CbGpPWpGaD
Zonisamide—CA9—Metabolism—DCN—uterine cancer	9.39e-05	0.000481	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—KRAS—uterine cancer	9.34e-05	0.000479	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKR1C3—uterine cancer	9.31e-05	0.000477	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—CTNNB1—uterine cancer	9.31e-05	0.000477	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—ERBB2—uterine cancer	9.29e-05	0.000476	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.29e-05	0.000476	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.29e-05	0.000476	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	9.25e-05	0.000474	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—VEGFA—uterine cancer	9.19e-05	0.000471	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—RRM2—uterine cancer	9.11e-05	0.000467	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—EP300—uterine cancer	9.1e-05	0.000466	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MET—uterine cancer	9.07e-05	0.000465	CbGpPWpGaD
Zonisamide—CA14—Metabolism—MTHFR—uterine cancer	9e-05	0.000461	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—KRAS—uterine cancer	8.97e-05	0.00046	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—KRAS—uterine cancer	8.97e-05	0.00046	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—CTNNB1—uterine cancer	8.91e-05	0.000456	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—DCN—uterine cancer	8.85e-05	0.000453	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP11A1—uterine cancer	8.84e-05	0.000453	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EP300—uterine cancer	8.81e-05	0.000452	CbGpPWpGaD
Zonisamide—CA6—Metabolism—MTHFR—uterine cancer	8.77e-05	0.00045	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—MTHFR—uterine cancer	8.77e-05	0.00045	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—STAR—uterine cancer	8.74e-05	0.000448	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKR1B1—uterine cancer	8.74e-05	0.000448	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—HRAS—uterine cancer	8.73e-05	0.000447	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	8.7e-05	0.000446	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EP300—uterine cancer	8.65e-05	0.000444	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—KRAS—uterine cancer	8.65e-05	0.000444	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—uterine cancer	8.62e-05	0.000442	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	8.58e-05	0.00044	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—CTNNB1—uterine cancer	8.56e-05	0.000439	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—CTNNB1—uterine cancer	8.56e-05	0.000439	CbGpPWpGaD
Zonisamide—CA13—Metabolism—AKT1—uterine cancer	8.52e-05	0.000437	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—NRAS—uterine cancer	8.51e-05	0.000436	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—HRAS—uterine cancer	8.45e-05	0.000433	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—HRAS—uterine cancer	8.45e-05	0.000433	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKR1C3—uterine cancer	8.35e-05	0.000428	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—uterine cancer	8.35e-05	0.000428	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP11A1—uterine cancer	8.33e-05	0.000427	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—HRAS—uterine cancer	8.3e-05	0.000425	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EP300—uterine cancer	8.28e-05	0.000424	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—CTNNB1—uterine cancer	8.25e-05	0.000423	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—NRAS—uterine cancer	8.24e-05	0.000423	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—uterine cancer	8.2e-05	0.00042	CbGpPWpGaD
Zonisamide—CA7—Metabolism—MTHFR—uterine cancer	8.19e-05	0.00042	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—MTHFR—uterine cancer	8.19e-05	0.00042	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	8.11e-05	0.000416	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—NRAS—uterine cancer	8.1e-05	0.000415	CbGpPWpGaD
Zonisamide—CA4—Metabolism—STK11—uterine cancer	8.05e-05	0.000413	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP19A1—uterine cancer	8.05e-05	0.000413	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—HRAS—uterine cancer	8.01e-05	0.00041	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EP300—uterine cancer	7.95e-05	0.000408	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EP300—uterine cancer	7.95e-05	0.000408	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—HRAS—uterine cancer	7.94e-05	0.000407	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKR1C3—uterine cancer	7.87e-05	0.000403	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—uterine cancer	7.84e-05	0.000402	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTEN—uterine cancer	7.77e-05	0.000398	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN2B—uterine cancer	7.77e-05	0.000398	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—NRAS—uterine cancer	7.74e-05	0.000397	CbGpPWpGaD
Zonisamide—CA2—Metabolism—STK11—uterine cancer	7.72e-05	0.000396	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP19A1—uterine cancer	7.72e-05	0.000396	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—uterine cancer	7.7e-05	0.000395	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EP300—uterine cancer	7.67e-05	0.000393	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—HRAS—uterine cancer	7.63e-05	0.000391	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—HRAS—uterine cancer	7.63e-05	0.000391	CbGpPWpGaD
Zonisamide—CA12—Metabolism—MTHFR—uterine cancer	7.59e-05	0.000389	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—uterine cancer	7.53e-05	0.000386	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—uterine cancer	7.53e-05	0.000386	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—AKT1—uterine cancer	7.46e-05	0.000382	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—NRAS—uterine cancer	7.44e-05	0.000381	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—NRAS—uterine cancer	7.44e-05	0.000381	CbGpPWpGaD
Zonisamide—CA3—Metabolism—EP300—uterine cancer	7.41e-05	0.00038	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP19A1—uterine cancer	7.4e-05	0.000379	CbGpPWpGaD
Zonisamide—CA1—Metabolism—STK11—uterine cancer	7.4e-05	0.000379	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—HRAS—uterine cancer	7.36e-05	0.000377	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—KRAS—uterine cancer	7.33e-05	0.000376	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—uterine cancer	7.26e-05	0.000372	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP19A1—uterine cancer	7.26e-05	0.000372	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—STK11—uterine cancer	7.26e-05	0.000372	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—NRAS—uterine cancer	7.17e-05	0.000368	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—uterine cancer	7.16e-05	0.000367	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—KRAS—uterine cancer	7.1e-05	0.000364	CbGpPWpGaD
Zonisamide—AOX1—Disease—SMAD3—uterine cancer	7.09e-05	0.000364	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—AKT1—uterine cancer	7.07e-05	0.000362	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—NRAS—uterine cancer	7.07e-05	0.000362	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—KRAS—uterine cancer	6.97e-05	0.000357	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—POLD1—uterine cancer	6.86e-05	0.000352	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.82e-05	0.000349	CbGpPWpGaD
Zonisamide—AOX1—Disease—FGFR2—uterine cancer	6.76e-05	0.000347	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—KRAS—uterine cancer	6.67e-05	0.000342	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ERBB2—uterine cancer	6.63e-05	0.00034	CbGpPWpGaD
Zonisamide—AOX1—Disease—MTHFR—uterine cancer	6.51e-05	0.000334	CbGpPWpGaD
Zonisamide—CA9—Metabolism—STK11—uterine cancer	6.51e-05	0.000333	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP19A1—uterine cancer	6.51e-05	0.000333	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKR1C1—uterine cancer	6.41e-05	0.000329	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	6.4e-05	0.000328	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KRAS—uterine cancer	6.4e-05	0.000328	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KRAS—uterine cancer	6.4e-05	0.000328	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	6.32e-05	0.000324	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—HRAS—uterine cancer	6.23e-05	0.000319	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KRAS—uterine cancer	6.17e-05	0.000316	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—STK11—uterine cancer	6.13e-05	0.000314	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP19A1—uterine cancer	6.13e-05	0.000314	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KRAS—uterine cancer	6.08e-05	0.000312	CbGpPWpGaD
Zonisamide—CA4—Metabolism—MTHFR—uterine cancer	6.05e-05	0.00031	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—HRAS—uterine cancer	6.03e-05	0.000309	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—HRAS—uterine cancer	5.92e-05	0.000304	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CTNNB1—uterine cancer	5.8e-05	0.000297	CbGpPWpGaD
Zonisamide—CA2—Metabolism—MTHFR—uterine cancer	5.8e-05	0.000297	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NDUFB11—uterine cancer	5.72e-05	0.000293	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SRD5A2—uterine cancer	5.72e-05	0.000293	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—RRM2—uterine cancer	5.72e-05	0.000293	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—HRAS—uterine cancer	5.67e-05	0.00029	CbGpPWpGaD
Zonisamide—CA1—Metabolism—MTHFR—uterine cancer	5.56e-05	0.000285	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.56e-05	0.000285	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—DCN—uterine cancer	5.55e-05	0.000285	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—AKT1—uterine cancer	5.5e-05	0.000282	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PIK3CA—uterine cancer	5.48e-05	0.000281	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—MTHFR—uterine cancer	5.45e-05	0.00028	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—HRAS—uterine cancer	5.44e-05	0.000279	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—HRAS—uterine cancer	5.44e-05	0.000279	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—HRAS—uterine cancer	5.44e-05	0.000279	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EP300—uterine cancer	5.39e-05	0.000276	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—AKT1—uterine cancer	5.33e-05	0.000273	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.25e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—HRAS—uterine cancer	5.25e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—AKT1—uterine cancer	5.23e-05	0.000268	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP11A1—uterine cancer	5.23e-05	0.000268	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—HRAS—uterine cancer	5.17e-05	0.000265	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—uterine cancer	5.11e-05	0.000262	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NRAS—uterine cancer	5.04e-05	0.000259	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTEN—uterine cancer	5.01e-05	0.000257	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—AKT1—uterine cancer	5e-05	0.000256	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKR1C3—uterine cancer	4.94e-05	0.000253	CbGpPWpGaD
Zonisamide—CA9—Metabolism—MTHFR—uterine cancer	4.89e-05	0.000251	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTEN—uterine cancer	4.88e-05	0.00025	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTEN—uterine cancer	4.88e-05	0.00025	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—AKT1—uterine cancer	4.81e-05	0.000246	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—AKT1—uterine cancer	4.81e-05	0.000246	CbGpPWpGaD
Zonisamide—CA14—Metabolism—EP300—uterine cancer	4.78e-05	0.000245	CbGpPWpGaD
Zonisamide—CA6—Metabolism—EP300—uterine cancer	4.65e-05	0.000239	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—EP300—uterine cancer	4.65e-05	0.000239	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—AKT1—uterine cancer	4.63e-05	0.000238	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—MTHFR—uterine cancer	4.61e-05	0.000236	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTEN—uterine cancer	4.56e-05	0.000233	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTEN—uterine cancer	4.56e-05	0.000233	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AKT1—uterine cancer	4.48e-05	0.00023	CbGpPWpGaD
Zonisamide—CA7—Metabolism—EP300—uterine cancer	4.34e-05	0.000223	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—EP300—uterine cancer	4.34e-05	0.000223	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—uterine cancer	4.34e-05	0.000223	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB2—uterine cancer	4.25e-05	0.000218	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTEN—uterine cancer	4.22e-05	0.000216	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—uterine cancer	4.17e-05	0.000214	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKR1B1—uterine cancer	4.14e-05	0.000212	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—STAR—uterine cancer	4.14e-05	0.000212	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.09e-05	0.00021	CbGpPWpGaD
Zonisamide—CA12—Metabolism—EP300—uterine cancer	4.02e-05	0.000206	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1B—uterine cancer	3.93e-05	0.000202	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—STK11—uterine cancer	3.85e-05	0.000197	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP19A1—uterine cancer	3.85e-05	0.000197	CbGpPWpGaD
Zonisamide—AOX1—Disease—CTNNB1—uterine cancer	3.72e-05	0.00019	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—uterine cancer	3.69e-05	0.000189	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—uterine cancer	3.62e-05	0.000186	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—uterine cancer	3.53e-05	0.000181	CbGpPWpGaD
Zonisamide—AOX1—Disease—EP300—uterine cancer	3.45e-05	0.000177	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—uterine cancer	3.44e-05	0.000176	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—uterine cancer	3.44e-05	0.000176	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.44e-05	0.000176	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.44e-05	0.000176	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—uterine cancer	3.37e-05	0.000173	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—uterine cancer	3.26e-05	0.000167	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—POLD1—uterine cancer	3.25e-05	0.000166	CbGpPWpGaD
Zonisamide—AOX1—Disease—NRAS—uterine cancer	3.23e-05	0.000166	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—uterine cancer	3.23e-05	0.000165	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—uterine cancer	3.21e-05	0.000165	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—uterine cancer	3.21e-05	0.000165	CbGpPWpGaD
Zonisamide—CA4—Metabolism—EP300—uterine cancer	3.21e-05	0.000165	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—uterine cancer	3.09e-05	0.000159	CbGpPWpGaD
Zonisamide—CA2—Metabolism—EP300—uterine cancer	3.08e-05	0.000158	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKR1C1—uterine cancer	3.04e-05	0.000156	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—uterine cancer	3.03e-05	0.000155	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—uterine cancer	2.98e-05	0.000153	CbGpPWpGaD
Zonisamide—CA1—Metabolism—EP300—uterine cancer	2.95e-05	0.000151	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—EP300—uterine cancer	2.89e-05	0.000148	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—uterine cancer	2.89e-05	0.000148	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—uterine cancer	2.89e-05	0.000148	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—uterine cancer	2.81e-05	0.000144	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—uterine cancer	2.81e-05	0.000144	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—uterine cancer	2.78e-05	0.000143	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—uterine cancer	2.72e-05	0.000139	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—RRM2—uterine cancer	2.71e-05	0.000139	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—DCN—uterine cancer	2.63e-05	0.000135	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—uterine cancer	2.63e-05	0.000135	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—uterine cancer	2.63e-05	0.000135	CbGpPWpGaD
Zonisamide—CA9—Metabolism—EP300—uterine cancer	2.59e-05	0.000133	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—uterine cancer	2.56e-05	0.000131	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—uterine cancer	2.56e-05	0.000131	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—STAR—uterine cancer	2.49e-05	0.000128	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.49e-05	0.000128	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.48e-05	0.000127	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—EP300—uterine cancer	2.44e-05	0.000125	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—uterine cancer	2.43e-05	0.000125	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—uterine cancer	2.37e-05	0.000122	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—uterine cancer	2.36e-05	0.000121	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.34e-05	0.00012	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—uterine cancer	2.28e-05	0.000117	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—uterine cancer	2.18e-05	0.000112	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—uterine cancer	2.14e-05	0.00011	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—uterine cancer	2.09e-05	0.000107	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—POLD1—uterine cancer	1.95e-05	0.0001	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—uterine cancer	1.94e-05	9.94e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—uterine cancer	1.92e-05	9.83e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—uterine cancer	1.86e-05	9.53e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.83e-05	9.36e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.82e-05	9.33e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—STK11—uterine cancer	1.82e-05	9.33e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—uterine cancer	1.81e-05	9.27e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—uterine cancer	1.78e-05	9.14e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—uterine cancer	1.75e-05	8.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.71e-05	8.76e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.63e-05	8.36e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RRM2—uterine cancer	1.63e-05	8.34e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—uterine cancer	1.61e-05	8.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—DCN—uterine cancer	1.58e-05	8.1e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—uterine cancer	1.57e-05	8.03e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—EP300—uterine cancer	1.53e-05	7.86e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.49e-05	7.63e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—uterine cancer	1.48e-05	7.57e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.41e-05	7.21e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—uterine cancer	1.37e-05	7.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.21e-05	6.18e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—uterine cancer	1.13e-05	5.82e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.1e-05	5.61e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—STK11—uterine cancer	1.1e-05	5.61e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—uterine cancer	9.27e-06	4.75e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—uterine cancer	8.23e-06	4.22e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—uterine cancer	7.61e-06	3.9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—EP300—uterine cancer	7.26e-06	3.72e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—uterine cancer	5.37e-06	2.75e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—uterine cancer	4.58e-06	2.35e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—uterine cancer	4.39e-06	2.25e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—EP300—uterine cancer	4.37e-06	2.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.23e-06	1.66e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—uterine cancer	2.64e-06	1.35e-05	CbGpPWpGaD
